nach oben

Erschienen in:

01.08.2013 | Original Article

Retinal heat shock protein 25 in early experimental diabetes

verfasst von: Silvia Pinach, Davina Burt, Elena Berrone, Federica Barutta, Graziella Bruno, Massimo Porta, Paolo Cavallo Perin, Gabriella Gruden

Erschienen in: Acta Diabetologica | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Diabetic retinopathy is the leading cause of blindness in adults, and oxidative stress has been pathogenically associated with retinal neurodegeneration. Cellular stresses induce expression of heat shock proteins (HSPs) and this results in cytoprotection. Our aim was to assess retinal expression of HSP25 in early experimental diabetes. Mice were rendered diabetic by streptozotocin injection. Ten weeks after diabetes onset retinal HSP25 expression were studied by real-time PCR, immunoblotting and immunohistochemistry (IHC). Expression of nitrotyrosine and Cu/Zn superoxide dismutase (SOD), was assessed by IHC and apoptosis by TUNEL. Retinal HSP25 mRNA and protein expression was significantly increased in diabetic as compared to non-diabetic animals and localised predominantly within the retinal ganglion cells (RGC) layer. This was paralleled overexpression of nitrotyrosine and SOD and enhanced apoptosis. In early experimental diabetes, HSP25 is overexpressed in the RGC layer in parallel with markers of oxidative stress and apoptosis.

Porta M, Bandello F (2002) Diabetic retinopathy. A clinical update. Diabetologia 45:1617–1634PubMedCrossRef

Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW (1998) Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest 102:783–791PubMedCrossRef

Martin PM, Roon P, Van Ells TK, Ganapathy V, Smith SB (2004) Death of retinal neurons in streptozotocin-induced diabetic mice. Invest Ophthalmol Vis Sci 45:3330–3336PubMedCrossRef

Kern TS, Barber AJ (2008) Retinal ganglion cells in diabetes. J Physiol 586:4401–4408PubMedCrossRef

Fink AL (1999) Chaperone-mediated protein folding. Physiol Rev 79:425–449PubMed

Kim HJ, Hwang NR, Lee KJ (2007) Heat shock responses for understanding diseases of protein denaturation. Mol Cells 23:123–131PubMed

Kim HP, Morse D, Choi AM (2006) Heat-shock proteins: new keys to the development of cytoprotective therapies. Expert Opin Ther Targets 10:759–769PubMedCrossRef

Welsh MJ, Gaestel M (1998) Small heat shock protein family: function in health and disease. Ann NY Acad Sci 851:28–35PubMedCrossRef

Dean DO, Tytell M (2001) HSP25 and -90 immunoreactivity in the normal rat eye. Invest Ophthalmol Vis Sci 42:3031–3040PubMed

10.

Hebb MO, Myers TL, Clarke MB (2006) Enhanced expression of heat shock protein 27 is correlated with axonal regeneration in mature retinal ganglion cells. Brain Res 1073–1074:46–150

11.

Kalesnykas G, Niittykoski M, Rantala J, Miettinen R, Salminen A, Kaarniranta K, Uusitalo H (2007) The expression of heat shock protein 27 in retinal ganglion and glial cells in a rat glaucoma model. Neuroscience 150:692–704PubMedCrossRef

12.

Krueger-Naug AMR, Emsley JG, Myers TL, Currie RW, Clarke DB (2002) Injury to retinal ganglion cells induces expression of the small heat shock protein Hsp27 in the rat visual system. Neuroscience 110:653–665PubMedCrossRef

13.

Li Y, Roth S, Laser M, Ma JX, Crosson CE (2003) Retinal preconditioning and the induction of heat shock protein 27. Invest Ophthalmol Vis Sci 44:1299–1304PubMedCrossRef

14.

Park JW, Moon C, Yun S, Kim SY, Bae YC, Chun MH, Moon JI (2007) Differential expression of heat shock protein mRNAs under in vivo glutathione depletion in the mouse retina. Neurosci Lett 413:260–264PubMedCrossRef

15.

Breyer MD, Bottinger E, Brosius FC III, Coffman TM, Harris RC, Heilig CW, Sharma K (2005) AMDCC. Mouse models of diabetic nephropathy. J Am Soc Nephrol 16:27–45PubMedCrossRef

16.

Barnstable CJ, Dräger UC (1984) Thy-1 antigen: a ganglion cell specific marker in rodent retina. Neuroscience 11:847–855PubMedCrossRef

17.

Nash MS, Osborne NN (1999) Assessment of Thy-1 mRNA levels as an index of retinal ganglion cell damage. Invest Ophthalmol Vis Sci 40:1293–1298PubMed

18.

Zhang J, Wu SM, Gross RL (2003) Effects of beta-adrenergic blockers on glutamate-induced calcium signals in adult mouse retinal ganglion cells. Brain Res 959:111–119PubMedCrossRef

19.

Whitlock NA, Agarwal N, Ma JX, Crosson CE (2005) Hsp27 upregulation by HIF-1 signaling offers protection against retinal ischemia in rats. Invest Ophthalmol Vis Sci 46:1092–1098PubMedCrossRef

20.

Yokoyama A, Oshitari T, Negishi H, Dezawa M, Mizota A, Adachi-Usami E (2001) Protection of retinal ganglion cells from ischemia-reperfusion injury by electrically applied Hsp27. Invest Ophthalmol Vis Sci 42:3283–3286PubMed

21.

Kowluru RA, Tang J, Kern TS (2001) Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII Effect of long-term administration of anti-oxidants on the development of retinopathy. Diabetes 50:1938–1942PubMedCrossRef

22.

Wyttenbach A, Sauvageot O, Carmichael J, Diaz-Latoud C, Arrigo AP, Rubinsztein DC (2002) Heat shock protein 27 prevents cellular polyglutamine toxicity and suppresses the increase of reactive oxygen species caused by huntingtin. Hum Mol Genet 11:1137–1151PubMedCrossRef

23.

Mehlen P, Kretz-Remy C, Préville X, Arrigo AP (1996) Human hsp27, Drosophila hsp27 and human alphaB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNF-a-induced cell death. EMBO J 15:2695–2706PubMed

24.

Behar-Cohen FF, Heydolph S, Faure V, Droy-Lefaix MT, Courtois Y, Goureau O (1996) Peroxynitrite cytotoxicity on bovine retinal pigmented epithelial cells in culture. Biochem Biophys Res Commun 226:842–849PubMedCrossRef

25.

Kowluru RA, Koppolu P (2002) Diabetes-induced activation of caspase-3 in retina: effect of antioxidant therapy. Free Rad Res 36:993–999CrossRef

26.

Kowluru RA (2003) Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes 52:818–823PubMedCrossRef

27.

Cheung AK, Fung MK, Lo AC, Lam TT, So KF, Chung SS, Chung SK (2005) Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice. Diabetes 54:3119–3125PubMedCrossRef

28.

Obrosova IG, Drel VR, Kumagai AK, Szábo C, Pacher P, Stevens MJ (2006) Early diabetes-induced biochemical changes in the retina: comparison of rat and mouse models. Diabetologia 49:2525–2533PubMedCrossRef

29.

Whitlock NA, Lindsey K, Agarwal N, Crosson CE, Ma JX (2005) Heat shock protein 27 delays Ca2+-induced cell death in a caspase-dependent and -independent manner in rat retinal ganglion cells. Invest Ophthalmol Vis Sci 46:1085–1091PubMedCrossRef

30.

Kretz A, Schmeer C, Tausch S, Isenmann S (2006) Simvastatin promotes heat shock protein 27 expression and AKT activation in the rat retina and promotes axotomized retinal ganglion cells in vivo. Neurobiol Dis 21:421–430PubMedCrossRef

31.

Concannon CG, Orrenius S, Samali A (2001) Hsp27 inhibits cytochrome c-mediated caspase activation by sequestering both pro-caspase-3 and cytochrome c. Gene Expr 9:195–201PubMed

32.

Garrido C, Bruey JM, Fromentin A, Hammann A, Arrigo AP, Solary E (1999) HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J 13:2061–2070PubMed

33.

Mehlen P, Schulze-Osthoff K, Arrigo AP (1996) Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J Biol Chem 271:16510–16514PubMedCrossRef

34.

Samali A, Cotter TG (1996) Heat shock proteins increase resistance to apoptosis. Exp Cell Res 223:163–170PubMedCrossRef

35.

Oshitari T, Roy S (2005) Diabetes: a potential enhancer of retinal injury in rat retinas. Neurosci Lett 390:25–30PubMedCrossRef

Titel: Retinal heat shock protein 25 in early experimental diabetes
verfasst von: Silvia Pinach
Davina Burt
Elena Berrone
Federica Barutta
Graziella Bruno
Massimo Porta
Paolo Cavallo Perin
Gabriella Gruden
Publikationsdatum: 01.08.2013
Verlag: Springer Milan
Erschienen in: Acta Diabetologica / Ausgabe 4/2013
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-011-0346-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2013

Angiogenesis regulatory factors in the vitreous from patients with proliferative diabetic retinopathy

Early management of type 2 diabetes based on a SMBG strategy: the way to diabetes regression—the St Carlos study

Myocardial dysfunction and chronic heart failure in patients with long-lasting type 1 diabetes: a 7-year prospective cohort study

Trans fatty acids consumption in type 1 diabetic patients: evaluation by dietary records and measurement in serum phospholipids

Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes